Company History

Company History



From a small tissue bank at the University of Florida to a global surgical implant company with four world-class manufacturing facilities, RTI Surgical (RTI) has a history of innovation.


Tutoplast® Tissue Sterilization Process developed

January 1969

The Tutoplast Tissue Sterilization Process was developed to sterilize and preserve tissue for implantation. The Tutoplast Process inactivates pathogens and removes bacteria, and the low dose gamma irradiation ensures sterility of the final packaged product.

Pioneer® Surgical Technology Formed

May 1992

Dr. Matthew Songer, an orthopedic surgeon, founded Pioneer in 1992 in Marquette, MI. Songer was not satisfied with the spinal cables on the market, which encouraged him to develop his own, a product we still distribute, called the Songer® Spinal Cable.

Tutogen Medical® formed

October 1992

In October 1992, Tutogen Medical (Tutogen) forms and builds its headquarters in Neunkirchen am Brand, Germany. Tutogen manufactures safe, high-quality xenograft and allograft implants for use in surgeries around the globe.

Precision tooled allograft introduced

January 1996

The first allograft to be precision tooled, a threaded cortical dowel, was introduced by University of Florida Tissue Bank.

Tutogen expands to Florida

January 1998

Tutogen expands to the United States by moving its corporate headquarters to Progress Park in Alachua, Fla.

Regeneration Technologies, Inc. begins operations

February 1998

RTI began operations as Regeneration Technologies in Alachua, Fla. In February 1998, the University of Florida Tissue Bank transferred its allograft processing operations, related equipment and technologies, distribution arrangements, and research and development activities to Regeneration Technologies. This spin off from the University of Florida (UF) is one of the most successful UF technology transfers to date.

BioCleanse® Tissue Sterilization Process developed

March 2000

In March 2000, RTI made history in the allograft industry by developing its patented BioCleanse Sterilization Process. The BioCleanse Process is a low-temperature chemical sterilization process that inactivates or removes bacteria, fungi, spores and viruses from tissue without compromising the tissue’s biocompatibility or structural integrity.

RTI listed on NASDAQ®

August 2000

RTI completed an initial public offering in August 2000 and began trading on the NASDAQ stock exchange under the symbol RTIX.

Assembled Implant Patent

August 2002

US Patent for assembled bone implants issued on August 6, 2002.

Regeneration Technologies merges with Tutogen to form RTI Biologics®

February 2008

In February 2008, Regeneration Technologies became a global company after merging with Tutogen, creating RTI Biologics, Inc. Both companies were located in Progress Park in Alachua, Fla. Following the merger, RTI became one of the leading providers of sterile biologic implants for surgeries, offering surgeons both allograft and xenograft implants.

RTI Biologics acquires Pioneer Surgical Technology to form RTI Surgical®

July 2013

RTI acquired Marquette, Mich.-based Pioneer® Surgical Technology, Inc., a global manufacturer of metal and synthetic implants, becoming RTI Surgical. In July 2013, the acquisition resulted in an expanded product portfolio. Today, RTI provides surgeons with safe biologic, metal and synthetic-based implants.